急性呼吸窘迫综合征
病危
2019年冠状病毒病(COVID-19)
医学
重症监护医学
2019-20冠状病毒爆发
静脉血栓栓塞
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
危重病
大流行
病毒学
内科学
肺
血栓形成
爆发
传染病(医学专业)
疾病
作者
Yaroslava Longhitano,Fabrizio Racca,Christian Zanza,Andrea Piccioni,Andrea Audo,M Muncinelli,Roberto Santi,Daniela Kozel,Cristina Geraci,M. Taverna,Valeria Bonato,F Cassini,Francesco Vito
出处
期刊:DOAJ: Directory of Open Access Journals - DOAJ
日期:2020-09-01
被引量:11
摘要
Objective Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and has subsequently spread worldwide. An association between increased venous thromboembolism in patients with pneumonia-related to COVID-19 has not yet been well described. Patients and methods We aimed to illustrate cases of pulmonary thromboembolism in patients with acute respiratory distress syndrome related to COVID-19 treated in our intensive care unit. The medical records of patients affected by COVID-19 with acute respiratory distress syndrome in our institute from 1/3/2020 to 31/3/2020 were retrospectively reviewed. Results Our center registered a high prevalence of thromboembolic events among 62 patients affected by acute respiratory distress syndrome related to COVID-19 despite a regular antithrombotic prophylaxis. Out of these, 32 patients were transferred to other hospitals, and 30 were treated in our center. Venous thromboembolism was registered in 12 (19.3%) cases. In particular, 11 diagnoses of pulmonary embolism and 1 diagnosis of deep vein thrombosis were formulated. We described a case series of venous thromboembolism in nine patients treated in our Intensive Care Unit (ICU). Main pulmonary arteries were always involved in these patients. None of them died. Conclusions In conclusion, critically ill patients with ARDS related to COVID-19 may have an increased risk of VTE that could be a leading cause of mortality. These patients require a high index of clinical suspicion and an accurate diagnostic approach, in order to immediately start an appropriate anticoagulant treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI